CEO highlights the importance of addressing the link between hormonal imbalances and weight management
WELL Health Technologies Corp. has announced a significant development in its US-based subsidiary Wisp, with the launch of a new weight care vertical tailored to women facing hormonal imbalances.
According to a news release, the initiative aims to provide comprehensive solutions for women struggling with hormonal conditions, such as perimenopause, menopause, polycystic ovary syndrome (PCOS), and endometriosis, and weight management. This comes as several organizations across the country highlight October as Menopause Awareness Month.
Wisp, the largest dedicated women’s telehealth provider in the US with over 1.2 million patients, has introduced personalized, online consultations with access to four weight care solutions, including GLP-1 therapies such as Semaglutide. Additionally, the platform has debuted its first over-the-counter weight loss supplement to promote metabolic health.
Monica Cepak, CEO of Wisp, emphasized the importance of addressing the connection between hormonal imbalances and weight management.
“Wisp is committed to providing sustainable support for women’s weight loss journeys, addressing a critical yet overlooked aspect of women’s health,” Cepak said. “As the dialogue around obesity evolves, we recognize that underlying conditions — especially hormonal imbalances linked to perimenopause and menopause — remain under-researched, underdiagnosed, and undertreated.”
WELL Health Technologies noted GLP-1 therapies have proven to be effective in addressing both metabolic health and weight management, particularly in individuals affected by hormonal conditions.
“These treatments are reshaping healthcare by addressing weight management while enhancing metabolic health and alleviating hormonal challenges,” said Hamed Shahbazi, CEO of WELL Health Technologies.
Wisp’s weight care program includes:
- Semaglutide (Wegovy®): FDA-approved injectable medication
- Compounded Semaglutide: Subcutaneous and sublingual options
- Metabolic Support & GLP-1 Boost Capsules: Natural supplements designed to enhance metabolic function
The program includes access to pharmacy pickup or discreet delivery of medications, supported by online health consultations and ongoing monthly check-ins. Wisp is also enhancing its menopause offerings, adding products like Estriol Face Cream and hormone replacement therapies, ensuring that women at all stages of life receive the support they need.
WELL Health Technologies is a digital healthcare company dedicated to empowering healthcare providers through technology. The company’s platform includes management software, back-office solutions, and healthcare services that support more than 37,000 providers across North America.
